Sign in
Stories
Innovative Surgeon Elevates OSA Treatment
Share
Bambu Lab A1 Printer Recall
FDA Warns on CPAP Safety Issues
Philips Faces Stock Slump Over Sleep Apn...
Overview
API
Nyxoah appoints Dr. Maurits S. Boon, MD, a renowned surgeon, as Chief Medical Officer to advance OSA treatment. Dr. Boon's expertise in hypoglossal nerve stimulation therapy aligns with Nyxoah's mission to simplify sleep for patients, enhancing Genio's potential in the U.S. market.
Ask a question
How could Nyxoah's U.S. market entry influence the landscape of sleep disorder treatments?
How might Dr. Boon's expertise shape the future of OSA treatment globally?
What specific innovations does Genio offer that could transform OSA patient care?
Article Frequency
0.2
0.4
0.6
0.8
1.0
Jan 2024
Feb 2024
Mar 2024
Coverage